| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |